Related Experiment Video
Updated: Jul 12, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
[New management of phosphocalcic abnormalities in dialysis patient]
P Delanaye1, L Van Overmeire, B E Dusbois
1Service de Néphrologie-Dialyse, CHU Sart Tilman, Liège, Bilgique.
Abstract:
Disorders of the phosphocalcic metabolism are frequent in dialysis patients. Such disorders are difficult to treat and have negative impact on bone health, but also on cardiovascular mortality. Hyperphosphoremia is a strong predictor of cardiovascular mortality. New phosphate binders are now available in Belgium. A new molecule acting on the calcium receptor of the parathyroid glands is able to control secondary and tertiary hyperparathyroidism in dialysis patients. These new therapies, specific for dialysis patients, will be reviewed in this article.
Related Concept Videos
Peritoneal Dialysis III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi III: Medical Management
Hemodialysis III: Nursing Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi V: Nursing Management